New Jersey S 4017: Requires DOH to purchase xylazine test strips to be distributed to entities that provide authorized harm reduction services; makes appropriation.

Status: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (as of 2026-03-19)

State: New Jersey · Session: 222 · Bill: S 4017

Sponsors: Vitale, Joseph F.

View New Jersey S 4017 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.